Two years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal.

<h4>Background</h4>The risk of premature cardiovascular disease in patients with familial hypercholesterolemia (FH) can be profoundly reduced by cholesterol-lowering therapy, and current guidelines for FH advocate ambitious low-density lipoprotein cholesterol (LDL-C) goals. In the presen...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Roeland Huijgen, Iris Kindt, Sjoerd B J Verhoeven, Eric J G Sijbrands, Maud N Vissers, John J P Kastelein, Barbara A Hutten
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2010
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/aacec6727baa4906b11ca1389e4c5dd5
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!